Brian Boucher

Quantitative Chemical Proteomics for Identifying Candidate Drug Targets

Yoshiya Oda, Takashi Owa, Toshitaka Sato et al. · Analytical Chemistry · 2003 · 190 citations

Proteomic Technology, Quantitative Chemical Proteomics, Drug Target +15

Peripheral pharmacokinetics of apomorphine in humans

Stephen T. Gancher, William R. Woodward, Brian Boucher et al. · Annals of Neurology · 1989 · 135 citations

Toxicological screening of urine for drugs by liquid chromatography/time‐of‐flight mass spectrometry with automated target library search based on elemental formulas

Merja Gergov, Brian Boucher, Ilkka Ojanperä et al. · Rapid Communications in Mass Spectrometry · 2001 · 84 citations

Elemental Formulas, Drug Screening, Lc/tofms Method +19

Second-Generation Antibacterial Benzimidazole Ureas: Discovery of a Preclinical Candidate with Reduced Metabolic Liability

Anne‐Laure Grillot, Arnaud LeTiran, Dean Shannon et al. · Journal of Medicinal Chemistry · 2014 · 80 citations · Full text

Metabolomic Profiling, Reduced Metabolic Liability, Antimicrobial Chemotherapy +19

The short‐duration response to apomorphine: Implications for the mechanism of dopaminergic effects in parkinsonism

Stephen T. Gancher, William R. Woodward, Perry M. Gliessman et al. · Annals of Neurology · 1990 · 21 citations